Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Dura acquires distribution rights for Glaxo Wellcome dermatology product line

Oct. 6, 2000

FDA approves cream formulation of Allergan's Tazorac

Oct. 4, 2000

Italian researchers present newly discovered 5alpha-reductase isoform 1-selective inhibitors

Sep. 22, 2000

Clinical candidate for allergic cutaneous disorders selected at Japan Energy

Sep. 14, 2000

HGS advances clinical development of novel protein

Sep. 13, 2000

Schering-Plough seeks FDA approval of desloratadine for chronic idiopathic urticaria

Sep. 6, 2000

Ortec's treatment for venous ulcers continues to demonstrate superiority

Sep. 5, 2000

Advanced Tissue Sciences submits PMA for Dermagraft as treatment of diabetic foot ulcers

Aug. 29, 2000

Topical Paclitaxel Gel found safe in two phase I psoriasis trials

Aug. 29, 2000

Parke-Davis reports SAR of nonpeptide IL-8 receptor antagonists

Aug. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...